CAMPI, IRENE
CAMPI, IRENE
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia
2014 N. Schoenmakers, C. Moran, I. Campi, M. Agostini, O. Bacon, O. Rajanayagam, J. Schwabe, S. Bradbury, T. Barrett, F. Geoghegan, M. Druce, P. Beck-Peccoz, A. O'Toole, P. Clark, M. Bignell, G. Lyons, D. Halsall, M. Gurnell, K. Chatterjee
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy.
2013 I. Campi, G. Vannucchi, A. Minetti, D. Dazzi, S. Avignone, D. Covelli, N. Currò, R. Ratiglia, C. Guastella, L. Pignataro, P. Beck-Peccoz, M. Salvi
A rare mutation of thyroid hormone receptor beta gene in thyroid hormone resistance syndrome
2021 M. Del Prete, F. Muratori, I. Campi, G. Di Sacco, F. Vignati, D. Pellegrino, L. Persani
Analysis of a deiodinase 2 polymorphism (oRFa-Asp) in patients with Graves’ disease and controls : preliminary results
2006 G. Vannucchi, D. Mannavola, V. Cirello, I. Campi, M. Muzza, P. Beck-Peccoz, L. Fugazzola
B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases
2015 I. Campi, D. Tosi, S. Rossi, G. Vannucchi, D. Covelli, F. Colombo, E. Trombetta, L. Porretti, L. Vicentini, G. Cantoni, N. Currò, P. Beck-Peccoz, G. Bulfamante, M. Salvi
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy.
2020 G. Lanzolla, G. Vannucchi, I. Ionni, I. Campi, F. Sileo, E. Lazzaroni, M. Marinò
Clinical consequences of variable results in the measurement of free thyroid hormones : unusual presentation of a family with a novel variant in the THRB gene causing resistance to thyroid hormone syndrome
2021 I. Campi, M. Agostini, F. Marelli, T. De Filippis, B. Romartinez-Alonso, O. Rajanayagam, G. Rurale, I. Gentile, F. Spagnolo, M. Andreasi, F. Ferrau, S. Cannavo, L. Fugazzola, K.V. Chatterjee, L. Persani
DESCRIZIONE DI UN CASO DI SEVERA INSULINO-RESISTENZA E LIPODISTROFIA PARZIALE, CAUSATO DA UNA MUTAZIONE A CARICO DEL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA (PPAR-GAMMA): CARATTERIZZAZIONE CLINICA E MOLECOLARE.
2013 I. Campi
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe graves' orbitopathy : a randomized controlled study
2015 M. Salvi, G. Vannucchi, N. Currò, I. Campi, D. Covelli, D. Dazzi, S. Simonetta, C. Guastella, L. Pignataro, S. Avignone, P. Beck-Peccoz
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression
2006 M. Salvi, G. Vannucchi, I. Campi, S. Rossi, P. Bonara, F. Sbrozzi, C. Guastella, S. Avignone, G. Pirola, R. Ratiglia, P. Beck Peccoz
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy
2021 G.M. Vannucchi, I. Campi, D. Covelli, N. Curro, E. Lazzaroni, A. Palomba, D. Soranna, A. Zambon, L. Fugazzola, I. Muller, C. Guastella, M. Salvi
Fetal cell microchimerism : a protective role in autoimmune thyroid diseases
2015 V. Cirello, R. Rizzo, M. Crippa, I. Campi, D. Bortolotti, S. Bolzani, C. Colombo, G. Vannucchi, M.A. Maffini, F. de Liso, S. Ferrero, P. Finelli, L. Fugazzola
Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis
2009 G. Vannucchi, I. Campi, D. Covelli, D. Dazzi, N. Currò, S. Simonetta, R. Ratiglia, P. Beck Peccoz, M. Salvi
Impact of resistance to thyroid hormone on the cardiovascular system in adults
2009 M. Pulcrano, E.A. Palmieri, D. Mannavola, M. Ciulla, I. Campi, D. Covelli, G. Lombardi, B. Biondi, P. Beck Peccoz
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis
2012 L. Persani, M. Bonomi, A. Lleo, S. Pasini, F. Civardi, I. Bianchi, I. Campi, P. Finelli, M. Miozzo, C. Castronovo, S. Sirchia, M.E. Gershwin, P. Invernizzi
Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement
2012 Y. Sun, B. Bak, N. Schoenmakers, A..S..P. Van Trotsenburg, W. Oostdijk, P. Voshol, E. Cambridge, J.K. White, P. Le Tissier, S.N.M. Gharavy, J.P. Martinez-Barbera, W.H. Stokvis-Brantsma, T. Vulsma, M.J. Kempers, L. Persani, I. Campi, M. Bonomi, P. Beck-Peccoz, H. Zhu, T.M.E. Davis, A.C..S. Hokken-Koelega, D.G. Del Blanco, J.J. Rangasami, C.A.L. Ruivenkamp, J.F..J. Laros, M. Kriek, S.G. Kant, C.A.J. Bosch, N.R. Biermasz, N.M. Appelman-Dijkstra, E.P. Corssmit, G.C.J. Hovens, A.M. Pereira, J.T.D. Den Dunnen, M.G. Wade, M.H. Breuning, R.C. Hennekam, K. Chatterjee, M.T. Dattani, J.M. Wit, D.J. Bernard
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans
2010 E. Schoenmakers, M. Agostini, C. Mitchell, N. Schoenmakers, L. Papp, O. Rajanayagam, R. Padidela, L. Ceron Gutierrez, R. Doffinger, C. Prevosto, J. Luan, S. Montano, J. Lu, M. Castanet, N. Clemons, M. Groeneveld, P. Castets, M. Karbaschi, S. Aitken, A. Dixon, J. Williams, I. Campi, M. Blount, H. Burton, F. Muntoni, D. O'Donovan, A. Dean, A. Warren, C. Brierley, D. Baguley, P. Guicheney, R. Fitzgerald, A. Coles, H. Gaston, P. Todd, A. Holmgren, K.K. Khanna, M. Cooke, R. Semple, D. Halsall, N. Wareham, J. Schwabe, L. Grasso, P. Beck Peccoz, A. Ogunko, M. Dattani, M. Gurnell, K. Chatterjee
New immunomodulators in the treatment of Graves' ophthalmopathy
2008 M. Salvi, G. Vannucchi, I. Campi, N. Currò, P. Beck Peccoz
Pituitary tumours : TSH-secreting adenomas
2009 P. Beck Peccoz, L. Persani, D. Mannavola, I. Campi
Prevention of orbitopathy by oral or intravenous steroid prophylaxis in short duration Graves’ disease patients undergoing radioiodine ablation : A prospective randomized control trial study
2019 G. Vannucchi, D. Covelli, I. Campi, N. Curro, D. Dazzi, M. Rodari, G. Pepe, A. Chiti, C. Guastella, E. Lazzaroni, M. Salvi